Remepy

Remepy

Remepy enables pharma companies to launch software-drug combinations. Remepy apps are tailored to specific clinical indications and drug mechanisms of action, increasing the drug’s efficacy. Engagement with Remepy apps activates brain mechanisms with a downstream impact on the immune system and direct improvement of synaptic connectivity and neuroplasticity.

www.remepy.com

In The News

14.2.2024

Naftali Bennett and Michal Tsur unite at Remepy: Former PM joins Board for hybrid drug endeavor

This is the third high-tech board Bennett has joined since he left politics, previously joining AI cyber company Lasoo and quantum computing startup Quantum Source. Tsur and Bennett founded Cyota in 1999 together with Ben Enosh and Lior Golan and sold it to RSA Security in 2005 for $145 million.
Read More
14.2.2024

Naftali Bennett and Michal Tsur unite at Remepy: Former PM joins Board for hybrid drug endeavor

This is the third high-tech board Bennett has joined since he left politics, previously joining AI cyber company Lasoo and quantum computing startup Quantum Source. Tsur and Bennett founded Cyota in 1999 together with Ben Enosh and Lior Golan and sold it to RSA Security in 2005 for $145 million.
Read More